EUVIMEDEUVIMED entdecken
Crossref

Benefit of CHA2 DS2 -VASc Score in Predicting Implantable Cardioverter Defibrillator Shocks

Seyda GUNAY, Sabri SEYIS, Özge KURMUŞ

Cardiology & Vascular Research · 2018

DOI: 10.33425/2639-8486.1020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology & Vascular Research, 2018. Verfasst von Seyda GUNAY und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Implantable cardioverter defibrillators (ICDs) reduce the risk of sudden death in eligible patients.However, it is thought that there is a relationship between the ICD shocks and increased morbidity and mortality.In this study, we examined the relationship between ICD shocks and the CHA 2 DS 2 -VASc scoring, which has gained frequent use in predicting cardiac events recently. Material and Methods:Retrospective baseline characteristics and three-year follow-ups of patients with ICDs with appropriate indication were studied.Patients were divided into two groups: patients who have received ICD shock(s) and patients who have not received any ICD shock.These groups were compared for baseline characteristics and CHA 2 DS 2 -VASc scores.

Results

CHA 2 DS 2 -VASc scores of heart failure (HF) patients in our study population were significantly higher than those who did not receive any shock within three years following the ICD implantation.The rate of appropriate or inappropriate ICD shocks was %16 in the HF patients implanted with ICD for primary prevention while it was %66 in patients implanted with ICD for secondary prevention.The incidence of atrial fibrillation was 68% in 37 patients who received inappropriate shock while it was 7% in those who did not receive inappropriate shock (those who received appropriate shocks or did not receive any shock) (p

Zitieren

APA

GUNAY, S., SEYIS, S., & KURMUŞ, Ö. (2018). Benefit of CHA2 DS2 -VASc Score in Predicting Implantable Cardioverter Defibrillator Shocks. Cardiology & Vascular Research. https://doi.org/10.33425/2639-8486.1020

Vancouver

GUNAY S, SEYIS S, KURMUŞ Ö. Benefit of CHA2 DS2 -VASc Score in Predicting Implantable Cardioverter Defibrillator Shocks. Cardiology & Vascular Research. 2018. doi:10.33425/2639-8486.1020

BibTeX
@article{GUNAY2018,
  author = {GUNAY, Seyda and SEYIS, Sabri and KURMUŞ, Özge},
  title = {Benefit of CHA2 DS2 -VASc Score in Predicting Implantable Cardioverter Defibrillator Shocks},
  journal = {Cardiology & Vascular Research},
  year = {2018},
  doi = {10.33425/2639-8486.1020}
}
Kostenlos starten →